Article Details
Retrieved on: 2021-06-08 06:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The presentation has been delivered by AB Science Medical and Safety ... After unblinding the phase 2B/3 studies with masitinib, AB Science ran ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here